MINNEAPOLIS - Every year doctors diagnose anywhere between 5,000 to 6,000 Americans with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease.
Radicava is the first new drug for ALS in 22 years to become available in the United States.
KARE 11's Cory Hepola shows us how the local ALS community has been given some hope.